BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21953693)

  • 1. Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Tripoliti E; Strong L; Hickey F; Foltynie T; Zrinzo L; Candelario J; Hariz M; Limousin P
    Mov Disord; 2011 Nov; 26(13):2434-6. PubMed ID: 21953693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Speech Change After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease Patients: A 2-Year Prospective Study.
    Tanaka Y; Tsuboi T; Watanabe H; Nakatsubo D; Maesawa S; Kato S; Kajita Y; Sato M; Oodake R; Hattori M; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
    J Parkinsons Dis; 2020; 10(1):131-140. PubMed ID: 31884493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysphonia and Dysarthria in People With Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation: Effect of Frequency Modulation.
    Morello ANDC; Beber BC; Fagundes VC; Cielo CA; Rieder CRM
    J Voice; 2020 May; 34(3):477-484. PubMed ID: 30454944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysarthria and Speech Intelligibility Following Parkinson's Disease Globus Pallidus Internus Deep Brain Stimulation.
    Chiu SY; Tsuboi T; Hegland KW; Herndon NE; Shukla AW; Patterson A; Almeida L; Foote KD; Okun MS; Ramirez-Zamora A
    J Parkinsons Dis; 2020; 10(4):1493-1502. PubMed ID: 32955467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive voice treatment (LSVT®LOUD) for Parkinson's disease following deep brain stimulation of the subthalamic nucleus.
    Spielman J; Mahler L; Halpern A; Gilley P; Klepitskaya O; Ramig L
    J Commun Disord; 2011; 44(6):688-700. PubMed ID: 21724193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson's disease.
    Klostermann F; Ehlen F; Vesper J; Nubel K; Gross M; Marzinzik F; Curio G; Sappok T
    J Neurol Neurosurg Psychiatry; 2008 May; 79(5):522-9. PubMed ID: 17766427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria?
    Fabbri M; Zibetti M; Ferrero G; Accornero A; Guimaraes I; Rizzone MG; Romagnolo A; Ferreira JJ; Lopiano L
    Parkinsonism Relat Disord; 2019 Jul; 64():242-248. PubMed ID: 31060986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Articulation Features of Parkinson's Disease Patients with Subthalamic Nucleus Deep Brain Stimulation.
    Tanaka Y; Tsuboi T; Watanabe H; Kajita Y; Nakatsubo D; Fujimoto Y; Ohdake R; Ito M; Atsuta N; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
    J Parkinsons Dis; 2016 Oct; 6(4):811-819. PubMed ID: 27662325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of speech and voice disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study.
    Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Hattori M; Kawabata K; Hara K; Ito M; Fujimoto Y; Nakatsubo D; Maesawa S; Kajita Y; Katsuno M; Sobue G
    J Neural Transm (Vienna); 2017 Dec; 124(12):1547-1556. PubMed ID: 29098450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease.
    Tripoliti E; Zrinzo L; Martinez-Torres I; Frost E; Pinto S; Foltynie T; Holl E; Petersen E; Roughton M; Hariz MI; Limousin P
    Neurology; 2011 Jan; 76(1):80-6. PubMed ID: 21068426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Averaged Spectrum Descriptors of Dysarthria in Patients With Parkinson's Disease Treated With Subthalamic Nucleus Deep Brain Stimulation.
    Svihlik J; Novotny M; Tykalova T; Polakova K; Brozova H; Kryze P; Sousa M; Krack P; Tripoliti E; Ruzicka E; Jech R; Rusz J
    J Speech Lang Hear Res; 2022 Dec; 65(12):4690-4699. PubMed ID: 36472939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation.
    Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Yoneyama N; Hara K; Nakamura R; Watanabe H; Senda J; Atsuta N; Ito M; Hirayama M; Yamamoto M; Fujimoto Y; Kajita Y; Wakabayashi T; Sobue G
    J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):856-64. PubMed ID: 25280914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct subthalamic nucleus stimulation influences speech and voice quality in Parkinson's disease patients.
    Bobin M; Sulzer N; Bründler G; Staib M; Imbach LL; Stieglitz LH; Krauss P; Bichsel O; Baumann CR; Frühholz S
    Brain Stimul; 2024; 17(1):112-124. PubMed ID: 38272256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthalamic deep brain stimulation aggravates speech problems in Parkinson's disease: Objective and subjective analysis of the influence of stimulation frequency and electrode contact location.
    Phokaewvarangkul O; Boonpang K; Bhidayasiri R
    Parkinsonism Relat Disord; 2019 Sep; 66():110-116. PubMed ID: 31327627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep brain stimulation fine-tuning in Parkinson's disease: Short pulse width effect on speech.
    Fabbri M; Natale F; Artusi CA; Romagnolo A; Bozzali M; Giulietti G; Guimaraes I; Rizzone MG; Accornero A; Lopiano L; Zibetti M
    Parkinsonism Relat Disord; 2021 Jun; 87():130-134. PubMed ID: 34034153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
    Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
    Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lee Silverman Voice Treatment for dysarthria in patients with Parkinson's disease: a systematic review and meta-analysis.
    Yuan F; Guo X; Wei X; Xie F; Zheng J; Huang Y; Huang Z; Chang Z; Li H; Guo Y; Chen J; Guo J; Tang B; Deng B; Wang Q
    Eur J Neurol; 2020 Oct; 27(10):1957-1970. PubMed ID: 32539227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a Randomized Clinical Trial of Speech After Early Neurostimulation in Parkinson's Disease.
    Pinto S; Nebel A; Rau J; Espesser R; Maillochon P; Niebuhr O; Krack P; Witjas T; Ghio A; Cuartero MC; Timmermann L; Schnitzler A; Hesekamp H; Meier N; Müllner J; Hälbig TD; Möller B; Paschen S; Paschen L; Volkmann J; Barbe MT; Fink GR; Becker J; Reker P; Kühn AA; Schneider GH; Fraix V; Seigneuret E; Kistner A; Rascol O; Brefel-Courbon C; Ory-Magne F; Hartmann CJ; Wojtecki L; Fradet A; Maltête D; Damier P; Le Dily S; Sixel-Döring F; Benecke P; Weiss D; Wächter T; Pinsker MO; Régis J; Thobois S; Polo G; Houeto JL; Hartmann A; Knudsen K; Vidailhet M; Schüpbach M; Deuschl G;
    Mov Disord; 2023 Feb; 38(2):212-222. PubMed ID: 36461899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristic laryngoscopic findings in Parkinson's disease patients after subthalamic nucleus deep brain stimulation and its correlation with voice disorder.
    Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Yoneyama N; Hara K; Ito M; Hirayama M; Yamamoto M; Fujimoto Y; Kajita Y; Wakabayashi T; Sobue G
    J Neural Transm (Vienna); 2015 Dec; 122(12):1663-72. PubMed ID: 26254905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.